Latest news
ASX Quarterly Health Wrap: Regulatory wins, clinical progress and strategic growth - StockheadStockhead · Wed, 05 Aug 2026 05:57:53 GMTRecce Pharmaceuticals Issues Cleansing Notice Following Share Issue - KalkineKalkine · Tue, 04 Aug 2026 07:04:52 GMTRecce Pharmaceuticals Files Cleansing Notice After Issuing 250,000 Shares on July 31, 2026 - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 07:04:52 GMTRCE:ASX Announcement - Cleansing Notice - 04 Aug 2026 - Market IndexMarket Index · Tue, 04 Aug 2026 07:00:00 GMTRecce Pharmaceuticals Issues 250,000 Shares at $0.375 Each for Corporate Advisory Services - KalkineKalkine · Mon, 03 Aug 2026 00:42:42 GMTSuperbug Fighter Recce Pharmaceuticals (ASX:RCE) Steps Into the Global Biodefence Spotlight - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTRecce welcomes US$66.9bn biodefence plan - The AustralianThe Australian · Fri, 31 Jul 2026 07:00:00 GMTRecce Pharmaceuticals to Quote 6,051,250 New Shares at 40 Cents Following Placement - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMT